![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Peereboom David Supko Jeffrey Carson Kathryn Batchelor Tracy Phuphanich Surasak Lesser Glenn Mikkelson Tom Fisher Joy Desideri Serena He Xiaoying Grossman Stuart
Publisher: Springer Publishing Company
ISSN: 0167-594X
Source: Journal of Neuro-Oncology, Vol.100, Iss.2, 2010-11, pp. : 261-268
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Peereboom David Supko Jeffrey Carson Kathryn Batchelor Tracy Phuphanich Surasak Lesser Glenn Mikkelsen Tom Fisher Joy Desideri Serena He Xiaoying Grossman Stuart
Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phase II trial of temozolomide in children with recurrent high-grade glioma
By Ruggiero A. Cefalo G. Garré M.L. Massimino M. Colosimo C. Attinà G. Lazzareschi I. Maurizi P. Ridola V. Mazzarella G. Caldarelli M. Rocco C. Madon E. Abate M.E. Clerico A. Sandri A. Riccardi R.
Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. :